P. B. Mitchell and S. B. Harvey, Depression and the older medical patient-When and how to intervene, Maturitas, vol.79, issue.2, pp.153-162, 2014.

M. A. Steinman, C. S. Landefeld, G. E. Rosenthal, D. Berthenthal, S. Sen et al., Polypharmacy and Prescribing Quality in Older People, J Am Geriatr Soc, vol.54, issue.10, pp.1516-1539, 2006.

H. Nessighaoui, H. Géniaux, T. Dantoine, and M. Laroche, Médicaments et fragilité chez les personnes âgées. Vers une nouvelle entité : la fragilité pharmacologique ?, Thérapie, vol.71, issue.3, pp.275-284, 2016.

F. Paille, A. Maheut-bosser, and B. Hanesse, Les antidépresseurs dans le traitement de la dépression de la personne âgée: La médecine basée sur les preuves, NPG Neurol-Psychiatr-Gériatrie, vol.4, issue.21, pp.9-34, 2004.

A. T. Beekman, J. R. Copeland, and M. J. Prince, Review of community prevalence of depression in later life, Br J Psychiatry J Ment Sci, vol.174, pp.307-318, 1999.

F. Limosin, A. Manetti, M. René, and J. Schuster, Dépression du sujet âgé : données épidémiologiques, aspects cliniques et approches thérapeutiques spécifiques, NPG Neurol-Psychiatr-Gériatrie, vol.15, issue.89, pp.256-61, 2015.

S. Weyerer, S. Eifflaender-gorfer, L. Köhler, F. Jessen, W. Maier et al., Prevalence and risk factors for depression in non-demented primary care attenders aged 75 years and older, J Affect Disord, vol.111, issue.2, pp.153-63, 2008.

K. Krishnan, M. Delong, H. Kraemer, R. Carney, D. Spiegel et al., Comorbidity of depression with other medical diseases in the elderly, Biol Psychiatry, vol.52, issue.6, pp.559-88, 2002.

, INSEE. Pyramides des âges ? Bilan démographique 2017 | Insee

M. T. Heflin, Geriatric Health Maintenance [Updated, 201818.

, Direction de la Recherche, des Études, de l'Evaluation et des Statistiques. L'état de santé de la population en France-RAPPORT 2015, vol.326

T. Gallarda and H. Lôo, Dépression et personnes âgées, L'Encéphale. juin, vol.35, issue.3, pp.269-80, 2009.

O. Drunat, N. Waksman, P. Koskas, and C. Peyneau, Dépression du sujet âgé : l'affaire du gériatre, NPG Neurol-Psychiatr-Gériatrie, vol.14, issue.83, pp.255-263, 2014.

R. S. Marin, S. Firinciogullari, and R. C. Biedrzycki, The sources of convergence between measures of apathy and depression, J Affect Disord, vol.28, issue.1, pp.7-14, 1993.

P. Andreasen, E. Lönnroos, V. Euler-chelpin, and C. M. , Prevalence of depression among older adults with dementia living in low-and middle-income countries: a cross-sectional study, Eur J Public Health, vol.24, issue.1, pp.40-44, 2014.

M. Steinberg, H. Shao, P. Zandi, C. G. Lyketsos, K. A. Welsh-bohmer et al., Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study, Int J Geriatr Psychiatry, vol.23, issue.2, pp.170-177, 2008.

J. Bains, J. Birks, and T. Dening, Antidepressants for treating depression in dementia, Cochrane Database Syst Rev, issue.4, 2002.

D. Enache, B. Winblad, and D. Aarsland, Depression in dementia: epidemiology, mechanisms, and treatment, Curr Opin Psychiatry, vol.24, issue.6, pp.461-72, 2011.

C. Wang, S. Gao, H. C. Hendrie, J. Kesterson, N. L. Campbell et al., Antidepressant use in the elderly is associated with an increased risk of dementia, Alzheimer Dis Assoc Disord, vol.30, issue.2, pp.99-104, 2016.

C. Lee, C. Lin, F. Sung, J. Liang, and C. Kao, Antidepressant treatment and risk of dementia: a population-based, retrospective case-control study, J Clin Psychiatry, vol.77, issue.1, pp.117-139, 2016.

T. L. Mark, V. N. Joish, J. W. Hay, D. V. Sheehan, S. S. Johnston et al., Antidepressant Use in Geriatric Populations: The Burden of Side Effects and Interactions and Their Impact on Adherence and Costs, Am J Geriatr Psychiatry, vol.19, issue.3, pp.211-232, 12011.

R. M. Leipzig, R. G. Cumming, and M. E. Tinetti, Drugs and Falls in Older People: A Systematic Review and Meta-analysis: I. Psychotropic Drugs, J Am Geriatr Soc, vol.47, issue.1, pp.30-39, 1999.

J. C. Woolcott, K. J. Richardson, M. O. Wiens, B. Patel, J. Marin et al., Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons, Arch Intern Med, vol.169, issue.21, pp.1952-60, 2009.

M. Daurel-receveur, G. Miremont-salamé, A. Fourrier, P. Auriche, N. Moore et al., Effets indésirables des antidépresseurs chez le sujet âgé : analyse des notifications en France, Thérapie, vol.60, issue.1, pp.61-66, 2005.

, ANSM. Etat des lieux de la consommation des benzodiazépines-Point d'Information-ANSM : Agence nationale de sécurité du médicament et des produits de santé, 2017.

J. Lecadet, P. Vidal, B. Baris, N. Vallier, P. Fender et al., Médicaments psychotropes : consommation et pratiques de prescription en France métropolitaine. I. Données nationales, Rev Med Ass Maladie, vol.34, issue.2, pp.75-84, 2000.

M. Defrancesco, J. Marksteiner, W. W. Fleischhacker, and I. Blasko, Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature, Int J Neuropsychopharmacol, vol.18, issue.10, pp.1-11, 2015.

M. Elie, M. G. Cole, F. J. Primeau, and F. Bellavance, Delirium Risk Factors in Elderly Hospitalized Patients, J Gen Intern Med, vol.13, issue.3, pp.204-216, 1998.